The Highly Conserved Glycan at Asparagine 260 of HIV-1 gp120 Is Indispensable for Viral Entry

被引:26
作者
Francois, Katrien O. [1 ]
Balzarini, Jan [1 ]
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN GP120; CARBOHYDRATE-BINDING AGENTS; LINKED GLYCOSYLATION SITES; CYANOVIRIN-N; ANTIBODY; 2G12; TYPE-1; RESISTANCE; DELETIONS; PROTEIN;
D O I
10.1074/jbc.M111.274456
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Carbohydrate-binding agents bind to the N-glycans of HIV-1 envelope gp120 and prevent viral entry. Carbohydrate-binding agents can select for mutant viruses with deleted envelope glycans. Not all glycosylation motifs are mutated to the same extent. Site-directed mutagenesis revealed that deletions destroying the highly conserved (260)NGS(262) glycosylation motif resulted in non-infectious virus particles. We observed a significant lower CD4 binding in the case of the N260Q mutant gp120 virus strains, caused by a strikingly lower expression of gp120 and gp41 in the virus particle. In addition, the mutant N260Q HIV-1 envelope expressed in 293T cells was unable to form syncytia in co-cultures with U87.CD4.CXCR4.CCR5 cells, due to the lower expression of envelope protein on the surface of the transfected 293T cells. The detrimental consequence of this N-glycan deletion on virus infectivity could not be compensated for by the creation of novel glycosylation sites near this amino acid, leaving this uncovered envelope epitope susceptible to neutralizing antibody binding. Thus, the Asn-260 glycan in the gp120 envelope of HIV-1 represents a hot spot for targeting suicidal drugs or antibodies in a therapeutic effort to efficiently neutralize a broad array of virus strains.
引用
收藏
页码:42900 / 42910
页数:11
相关论文
共 46 条
[1]   EPITOPE MAPPING AND TOPOLOGY OF BACULOVIRUS-EXPRESSED HIV-1 GP160 DETERMINED WITH A PANEL OF MURINE MONOCLONAL-ANTIBODIES [J].
ABACIOGLU, YH ;
FOUTS, TR ;
LAMAN, JD ;
CLAASSEN, E ;
PINCUS, SH ;
MOORE, JP ;
ROBY, CA ;
KAMINLEWIS, R ;
LEWIS, GK .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) :371-381
[2]   Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention [J].
Auwerx, Joeri ;
Francois, Katrien O. ;
Covens, Kris ;
Van Laethem, Kristel ;
Balzarini, Jan .
VIROLOGY, 2008, 382 (01) :10-19
[3]   Inhibition of HIV entry by carbohydrate-binding proteins [J].
Balzarini, J. .
ANTIVIRAL RESEARCH, 2006, 71 (2-3) :237-247
[4]   Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis [J].
Balzarini, J ;
Van Laethem, K ;
Hatse, S ;
Froeyen, M ;
Van Damme, E ;
Bolmstedt, A ;
Peumans, W ;
De Clercq, E ;
Schols, D .
MOLECULAR PHARMACOLOGY, 2005, 67 (05) :1556-1565
[5]   Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins [J].
Balzarini, J ;
Van Laethem, K ;
Hatse, S ;
Vermeire, K ;
De Clercq, ER ;
Peumans, W ;
Van Damme, E ;
Vandamme, AM ;
Böhlmstedt, A ;
Schols, D .
JOURNAL OF VIROLOGY, 2004, 78 (19) :10617-10627
[6]   Carbohydrate-binding agents cause deletions of highly conserved glycosylation sites in HIV GP120 - A new therapeutic concept to hit the Achilles heel of HIV [J].
Balzarini, J ;
Van Laethem, K ;
Hatse, S ;
Froeyen, M ;
Peumans, W ;
Van Damme, E ;
Schols, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (49) :41005-41014
[7]   Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy [J].
Balzarini, Jan .
NATURE REVIEWS MICROBIOLOGY, 2007, 5 (08) :583-597
[8]   Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus [J].
Balzarini, Jan ;
Van Laethem, Kristel ;
Daelemans, Dirk ;
Hatse, Sigrid ;
Bugatti, Antonella ;
Rusnati, Marco ;
Igarashi, Yasuhlro ;
Oki, Toshikazu ;
Schols, Dominique .
JOURNAL OF VIROLOGY, 2007, 81 (01) :362-373
[9]   Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes [J].
Balzarini, Jan ;
Van Laethem, Kristel ;
Peumans, Willy J. ;
Van Damme, Els J. M. ;
Bolmstedt, Anders ;
Gago, Federico ;
Schols, Dominique .
JOURNAL OF VIROLOGY, 2006, 80 (17) :8411-8421
[10]   Pradimicin S, a Highly Soluble Nonpeptidic Small-Size Carbohydrate-Binding Antibiotic, Is an Anti-HIV Drug Lead for both Microbicidal and Systemic Use [J].
Balzarini, Jan ;
Francois, Katrien O. ;
Van Laethem, Kristel ;
Hoorelbeke, Bart ;
Renders, Marleen ;
Auwerx, Joeri ;
Liekens, Sandra ;
Oki, Toshikazu ;
Igarashi, Yasuhiro ;
Schols, Dominique .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (04) :1425-1435